Literature DB >> 22323926

Induction and function of type I and III interferon in response to viral infection.

David E Levy1, Isabelle J Marié, Joan E Durbin.   

Abstract

The type I and III interferon (IFN) families consist of cytokines rapidly induced during viral infection that confer antiviral protection on target cells and are critical components of innate immune responses and the transition to effective adaptive immunity. The regulation of their expression involves an intricate and stringently regulated signaling cascade, initiated by recognition most often of viral nucleic acid in cytoplasmic and endosomal compartments and involving a series of protein conformational rearrangements and interactions regulated by helicase action, ubiquitin modification, and protein aggregation, culminating in kinase activation and phosphorylation of critical transcription factors and their regulators. The many IFN subtypes induced by viruses confer amplification, diversification, and cell-type specificity to the host response to infection, providing fertile ground for development of antiviral therapeutics and vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22323926      PMCID: PMC3272644          DOI: 10.1016/j.coviro.2011.11.001

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  100 in total

Review 1.  Mechanisms of type III interferon expression.

Authors:  Marie B Iversen; Søren R Paludan
Journal:  J Interferon Cytokine Res       Date:  2010-08       Impact factor: 2.607

2.  Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections.

Authors:  Markus Mordstein; Eva Neugebauer; Vanessa Ditt; Birthe Jessen; Toni Rieger; Valeria Falcone; Frederic Sorgeloos; Stephan Ehl; Daniel Mayer; Georg Kochs; Martin Schwemmle; Stephan Günther; Christian Drosten; Thomas Michiels; Peter Staeheli
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Viral infections activate types I and III interferon genes through a common mechanism.

Authors:  Kazuhide Onoguchi; Mitsutoshi Yoneyama; Azumi Takemura; Shizuo Akira; Tadatsugu Taniguchi; Hideo Namiki; Takashi Fujita
Journal:  J Biol Chem       Date:  2007-01-04       Impact factor: 5.157

Review 4.  The IRF family, revisited.

Authors:  A Paun; P M Pitha
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

5.  Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation.

Authors:  Lai Wei; Golnaz Vahedi; Hong-Wei Sun; Wendy T Watford; Hiroaki Takatori; Haydee L Ramos; Hayato Takahashi; Jonathan Liang; Gustavo Gutierrez-Cruz; Chongzhi Zang; Weiqun Peng; John J O'Shea; Yuka Kanno
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

6.  Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo.

Authors:  Nancy A Jewell; Troy Cline; Sara E Mertz; Sergey V Smirnov; Emilio Flaño; Christian Schindler; Jessica L Grieves; Russell K Durbin; Sergei V Kotenko; Joan E Durbin
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

7.  Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection.

Authors:  Andrew J Muir; Mitchell L Shiffman; Atif Zaman; Boris Yoffe; Andrew de la Torre; Steven Flamm; Stuart C Gordon; Paul Marotta; John M Vierling; Juan Carlos Lopez-Talavera; Kelly Byrnes-Blake; David Fontana; Jeremy Freeman; Todd Gray; Diana Hausman; Naomi N Hunder; Eric Lawitz
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

Review 8.  Interferon-lambda: a new addition to an old family.

Authors:  Raymond P Donnelly; Sergei V Kotenko
Journal:  J Interferon Cytokine Res       Date:  2010-08       Impact factor: 2.607

9.  Functional crosstalk between type I and II interferon through the regulated expression of STAT1.

Authors:  Daniel J Gough; Nicole L Messina; Linda Hii; Jodee A Gould; Kanaga Sabapathy; Ashley P S Robertson; Joseph A Trapani; David E Levy; Paul J Hertzog; Christopher J P Clarke; Ricky W Johnstone
Journal:  PLoS Biol       Date:  2010-04-27       Impact factor: 8.029

10.  Heterocellular induction of interferon by negative-sense RNA viruses.

Authors:  S Chen; J A L Short; D F Young; M J Killip; M Schneider; S Goodbourn; R E Randall
Journal:  Virology       Date:  2010-09-15       Impact factor: 3.616

View more
  147 in total

Review 1.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virus.

Authors:  Sonja Schmid; David Sachs; Benjamin R tenOever
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

3.  Reduction of infection by inhibiting mTOR pathway is associated with reversed repression of type I interferon by porcine reproductive and respiratory syndrome virus.

Authors:  Qinfang Liu; Laura C Miller; Frank Blecha; Yongming Sang
Journal:  J Gen Virol       Date:  2017-06-14       Impact factor: 3.891

Review 4.  Stress, inflammation, and defense of homeostasis.

Authors:  Raj Chovatiya; Ruslan Medzhitov
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

5.  Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1.

Authors:  Alex M Agelidis; Satvik R Hadigal; Dinesh Jaishankar; Deepak Shukla
Journal:  Cell Rep       Date:  2017-07-11       Impact factor: 9.423

6.  Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection.

Authors:  Megan T Baldridge; Timothy J Nice; Broc T McCune; Christine C Yokoyama; Amal Kambal; Michael Wheadon; Michael S Diamond; Yulia Ivanova; Maxim Artyomov; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

7.  Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.

Authors:  Dane Parker
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

Review 8.  Constitutive type I interferon modulates homeostatic balance through tonic signaling.

Authors:  Daniel J Gough; Nicole L Messina; Christopher J P Clarke; Ricky W Johnstone; David E Levy
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

Review 9.  Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions.

Authors:  Sreedhar Chinnaswamy
Journal:  J Interferon Cytokine Res       Date:  2014-02-20       Impact factor: 2.607

10.  Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.

Authors:  Isabella Rauch; Felix Rosebrock; Eva Hainzl; Susanne Heider; Andrea Majoros; Sebastian Wienerroither; Birgit Strobl; Silvia Stockinger; Lukas Kenner; Mathias Müller; Thomas Decker
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.